Report Detail

Request for Sample of this report

Medical Devices & Consumables Global Artificial Organs and Bionics Market 2026 by Company, Regions, Type and Application, Forecast to 2032

  • RnM4664582
    • |
  • 19 January, 2026
    • |
  • Global
    • |
  • 157 Pages
    • |
  • GIR
    • |
  • Medical Devices & Consumables

According to our (Global Info Research) latest study, the global Artificial Organs and Bionics market size was valued at US$ 11500 million in 2025 and is forecast to a readjusted size of US$ 18640 million by 2032 with a CAGR of 7.2% during review period.
An artificial organ is a human made organ device or tissue that is implanted or integrated into a human — interfacing with living tissue — to replace a natural organ, to duplicate or augment a specific function or functions so the patient may return to a normal life as soon as possible. Bionic implants refer to electronic or mechatronic parts that augment or restore physical functionality to a differently-abled person.
North America is the largest market of Artificial Organs And Bionic Implants, with a share about 45%, followed by Europe and China, both have a share about 50 percent. Global top 5 companies include Fresenius Medical Care, Cochlear, Abiomed, ABBOTT and Baxter, they hold a share over 50%.
This report is a detailed and comprehensive analysis for global Artificial Organs and Bionics market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Artificial Organs and Bionics market size and forecasts, in consumption value ($ Million), 2021-2032
Global Artificial Organs and Bionics market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Artificial Organs and Bionics market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Artificial Organs and Bionics market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Artificial Organs and Bionics
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Artificial Organs and Bionics market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Fresenius Medical Care, Cochlear, Abiomed, ABBOTT, Baxter, B.Braun, Asahi Kasei Corporation, Nipro, MED-EL, Toray Medical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Artificial Organs and Bionics market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Artificial Kidney
Artificial Heart & Ventricular Assist Device
Cochlear Implant
Artificial Lung
Artificial Liver
Artificial Pancreas
Bionic Hands & Prosthetics
Others
Market segment by Application
Commercialize
Clinical Research
Market segment by players, this report covers
Fresenius Medical Care
Cochlear
Abiomed
ABBOTT
Baxter
B.Braun
Asahi Kasei Corporation
Nipro
MED-EL
Toray Medical
Sonova
Medtronic
Getinge (Maquet)
William Demant
LivaNova (Sorin)
Terumo
Hangzhou Nurotron
Syncardia
CorWave
Listent Medical
Evaheart
Open Bionics
OYMotion Technologies
Mobius Bionics
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Artificial Organs and Bionics product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Artificial Organs and Bionics, with revenue, gross margin, and global market share of Artificial Organs and Bionics from 2021 to 2026.
Chapter 3, the Artificial Organs and Bionics competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Artificial Organs and Bionics market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Artificial Organs and Bionics.
Chapter 13, to describe Artificial Organs and Bionics research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Artificial Organs and Bionics by Type
    • 1.3.1 Overview: Global Artificial Organs and Bionics Market Size by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Global Artificial Organs and Bionics Consumption Value Market Share by Type in 2025
    • 1.3.3 Artificial Kidney
    • 1.3.4 Artificial Heart & Ventricular Assist Device
    • 1.3.5 Cochlear Implant
    • 1.3.6 Artificial Lung
    • 1.3.7 Artificial Liver
    • 1.3.8 Artificial Pancreas
    • 1.3.9 Bionic Hands & Prosthetics
    • 1.3.10 Others
  • 1.4 Global Artificial Organs and Bionics Market by Application
    • 1.4.1 Overview: Global Artificial Organs and Bionics Market Size by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Commercialize
    • 1.4.3 Clinical Research
  • 1.5 Global Artificial Organs and Bionics Market Size & Forecast
  • 1.6 Global Artificial Organs and Bionics Market Size and Forecast by Region
    • 1.6.1 Global Artificial Organs and Bionics Market Size by Region: 2021 VS 2025 VS 2032
    • 1.6.2 Global Artificial Organs and Bionics Market Size by Region, (2021-2032)
    • 1.6.3 North America Artificial Organs and Bionics Market Size and Prospect (2021-2032)
    • 1.6.4 Europe Artificial Organs and Bionics Market Size and Prospect (2021-2032)
    • 1.6.5 Asia-Pacific Artificial Organs and Bionics Market Size and Prospect (2021-2032)
    • 1.6.6 South America Artificial Organs and Bionics Market Size and Prospect (2021-2032)
    • 1.6.7 Middle East & Africa Artificial Organs and Bionics Market Size and Prospect (2021-2032)

2 Company Profiles

  • 2.1 Fresenius Medical Care
    • 2.1.1 Fresenius Medical Care Details
    • 2.1.2 Fresenius Medical Care Major Business
    • 2.1.3 Fresenius Medical Care Artificial Organs and Bionics Product and Solutions
    • 2.1.4 Fresenius Medical Care Artificial Organs and Bionics Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Fresenius Medical Care Recent Developments and Future Plans
  • 2.2 Cochlear
    • 2.2.1 Cochlear Details
    • 2.2.2 Cochlear Major Business
    • 2.2.3 Cochlear Artificial Organs and Bionics Product and Solutions
    • 2.2.4 Cochlear Artificial Organs and Bionics Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Cochlear Recent Developments and Future Plans
  • 2.3 Abiomed
    • 2.3.1 Abiomed Details
    • 2.3.2 Abiomed Major Business
    • 2.3.3 Abiomed Artificial Organs and Bionics Product and Solutions
    • 2.3.4 Abiomed Artificial Organs and Bionics Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Abiomed Recent Developments and Future Plans
  • 2.4 ABBOTT
    • 2.4.1 ABBOTT Details
    • 2.4.2 ABBOTT Major Business
    • 2.4.3 ABBOTT Artificial Organs and Bionics Product and Solutions
    • 2.4.4 ABBOTT Artificial Organs and Bionics Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 ABBOTT Recent Developments and Future Plans
  • 2.5 Baxter
    • 2.5.1 Baxter Details
    • 2.5.2 Baxter Major Business
    • 2.5.3 Baxter Artificial Organs and Bionics Product and Solutions
    • 2.5.4 Baxter Artificial Organs and Bionics Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Baxter Recent Developments and Future Plans
  • 2.6 B.Braun
    • 2.6.1 B.Braun Details
    • 2.6.2 B.Braun Major Business
    • 2.6.3 B.Braun Artificial Organs and Bionics Product and Solutions
    • 2.6.4 B.Braun Artificial Organs and Bionics Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 B.Braun Recent Developments and Future Plans
  • 2.7 Asahi Kasei Corporation
    • 2.7.1 Asahi Kasei Corporation Details
    • 2.7.2 Asahi Kasei Corporation Major Business
    • 2.7.3 Asahi Kasei Corporation Artificial Organs and Bionics Product and Solutions
    • 2.7.4 Asahi Kasei Corporation Artificial Organs and Bionics Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Asahi Kasei Corporation Recent Developments and Future Plans
  • 2.8 Nipro
    • 2.8.1 Nipro Details
    • 2.8.2 Nipro Major Business
    • 2.8.3 Nipro Artificial Organs and Bionics Product and Solutions
    • 2.8.4 Nipro Artificial Organs and Bionics Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Nipro Recent Developments and Future Plans
  • 2.9 MED-EL
    • 2.9.1 MED-EL Details
    • 2.9.2 MED-EL Major Business
    • 2.9.3 MED-EL Artificial Organs and Bionics Product and Solutions
    • 2.9.4 MED-EL Artificial Organs and Bionics Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 MED-EL Recent Developments and Future Plans
  • 2.10 Toray Medical
    • 2.10.1 Toray Medical Details
    • 2.10.2 Toray Medical Major Business
    • 2.10.3 Toray Medical Artificial Organs and Bionics Product and Solutions
    • 2.10.4 Toray Medical Artificial Organs and Bionics Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Toray Medical Recent Developments and Future Plans
  • 2.11 Sonova
    • 2.11.1 Sonova Details
    • 2.11.2 Sonova Major Business
    • 2.11.3 Sonova Artificial Organs and Bionics Product and Solutions
    • 2.11.4 Sonova Artificial Organs and Bionics Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 Sonova Recent Developments and Future Plans
  • 2.12 Medtronic
    • 2.12.1 Medtronic Details
    • 2.12.2 Medtronic Major Business
    • 2.12.3 Medtronic Artificial Organs and Bionics Product and Solutions
    • 2.12.4 Medtronic Artificial Organs and Bionics Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 Medtronic Recent Developments and Future Plans
  • 2.13 Getinge (Maquet)
    • 2.13.1 Getinge (Maquet) Details
    • 2.13.2 Getinge (Maquet) Major Business
    • 2.13.3 Getinge (Maquet) Artificial Organs and Bionics Product and Solutions
    • 2.13.4 Getinge (Maquet) Artificial Organs and Bionics Revenue, Gross Margin and Market Share (2021-2026)
    • 2.13.5 Getinge (Maquet) Recent Developments and Future Plans
  • 2.14 William Demant
    • 2.14.1 William Demant Details
    • 2.14.2 William Demant Major Business
    • 2.14.3 William Demant Artificial Organs and Bionics Product and Solutions
    • 2.14.4 William Demant Artificial Organs and Bionics Revenue, Gross Margin and Market Share (2021-2026)
    • 2.14.5 William Demant Recent Developments and Future Plans
  • 2.15 LivaNova (Sorin)
    • 2.15.1 LivaNova (Sorin) Details
    • 2.15.2 LivaNova (Sorin) Major Business
    • 2.15.3 LivaNova (Sorin) Artificial Organs and Bionics Product and Solutions
    • 2.15.4 LivaNova (Sorin) Artificial Organs and Bionics Revenue, Gross Margin and Market Share (2021-2026)
    • 2.15.5 LivaNova (Sorin) Recent Developments and Future Plans
  • 2.16 Terumo
    • 2.16.1 Terumo Details
    • 2.16.2 Terumo Major Business
    • 2.16.3 Terumo Artificial Organs and Bionics Product and Solutions
    • 2.16.4 Terumo Artificial Organs and Bionics Revenue, Gross Margin and Market Share (2021-2026)
    • 2.16.5 Terumo Recent Developments and Future Plans
  • 2.17 Hangzhou Nurotron
    • 2.17.1 Hangzhou Nurotron Details
    • 2.17.2 Hangzhou Nurotron Major Business
    • 2.17.3 Hangzhou Nurotron Artificial Organs and Bionics Product and Solutions
    • 2.17.4 Hangzhou Nurotron Artificial Organs and Bionics Revenue, Gross Margin and Market Share (2021-2026)
    • 2.17.5 Hangzhou Nurotron Recent Developments and Future Plans
  • 2.18 Syncardia
    • 2.18.1 Syncardia Details
    • 2.18.2 Syncardia Major Business
    • 2.18.3 Syncardia Artificial Organs and Bionics Product and Solutions
    • 2.18.4 Syncardia Artificial Organs and Bionics Revenue, Gross Margin and Market Share (2021-2026)
    • 2.18.5 Syncardia Recent Developments and Future Plans
  • 2.19 CorWave
    • 2.19.1 CorWave Details
    • 2.19.2 CorWave Major Business
    • 2.19.3 CorWave Artificial Organs and Bionics Product and Solutions
    • 2.19.4 CorWave Artificial Organs and Bionics Revenue, Gross Margin and Market Share (2021-2026)
    • 2.19.5 CorWave Recent Developments and Future Plans
  • 2.20 Listent Medical
    • 2.20.1 Listent Medical Details
    • 2.20.2 Listent Medical Major Business
    • 2.20.3 Listent Medical Artificial Organs and Bionics Product and Solutions
    • 2.20.4 Listent Medical Artificial Organs and Bionics Revenue, Gross Margin and Market Share (2021-2026)
    • 2.20.5 Listent Medical Recent Developments and Future Plans
  • 2.21 Evaheart
    • 2.21.1 Evaheart Details
    • 2.21.2 Evaheart Major Business
    • 2.21.3 Evaheart Artificial Organs and Bionics Product and Solutions
    • 2.21.4 Evaheart Artificial Organs and Bionics Revenue, Gross Margin and Market Share (2021-2026)
    • 2.21.5 Evaheart Recent Developments and Future Plans
  • 2.22 Open Bionics
    • 2.22.1 Open Bionics Details
    • 2.22.2 Open Bionics Major Business
    • 2.22.3 Open Bionics Artificial Organs and Bionics Product and Solutions
    • 2.22.4 Open Bionics Artificial Organs and Bionics Revenue, Gross Margin and Market Share (2021-2026)
    • 2.22.5 Open Bionics Recent Developments and Future Plans
  • 2.23 OYMotion Technologies
    • 2.23.1 OYMotion Technologies Details
    • 2.23.2 OYMotion Technologies Major Business
    • 2.23.3 OYMotion Technologies Artificial Organs and Bionics Product and Solutions
    • 2.23.4 OYMotion Technologies Artificial Organs and Bionics Revenue, Gross Margin and Market Share (2021-2026)
    • 2.23.5 OYMotion Technologies Recent Developments and Future Plans
  • 2.24 Mobius Bionics
    • 2.24.1 Mobius Bionics Details
    • 2.24.2 Mobius Bionics Major Business
    • 2.24.3 Mobius Bionics Artificial Organs and Bionics Product and Solutions
    • 2.24.4 Mobius Bionics Artificial Organs and Bionics Revenue, Gross Margin and Market Share (2021-2026)
    • 2.24.5 Mobius Bionics Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Artificial Organs and Bionics Revenue and Share by Players (2021-2026)
  • 3.2 Market Share Analysis (2025)
    • 3.2.1 Market Share of Artificial Organs and Bionics by Company Revenue
    • 3.2.2 Top 3 Artificial Organs and Bionics Players Market Share in 2025
    • 3.2.3 Top 6 Artificial Organs and Bionics Players Market Share in 2025
  • 3.3 Artificial Organs and Bionics Market: Overall Company Footprint Analysis
    • 3.3.1 Artificial Organs and Bionics Market: Region Footprint
    • 3.3.2 Artificial Organs and Bionics Market: Company Product Type Footprint
    • 3.3.3 Artificial Organs and Bionics Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Artificial Organs and Bionics Consumption Value and Market Share by Type (2021-2026)
  • 4.2 Global Artificial Organs and Bionics Market Forecast by Type (2027-2032)

5 Market Size Segment by Application

  • 5.1 Global Artificial Organs and Bionics Consumption Value Market Share by Application (2021-2026)
  • 5.2 Global Artificial Organs and Bionics Market Forecast by Application (2027-2032)

6 North America

  • 6.1 North America Artificial Organs and Bionics Consumption Value by Type (2021-2032)
  • 6.2 North America Artificial Organs and Bionics Market Size by Application (2021-2032)
  • 6.3 North America Artificial Organs and Bionics Market Size by Country
    • 6.3.1 North America Artificial Organs and Bionics Consumption Value by Country (2021-2032)
    • 6.3.2 United States Artificial Organs and Bionics Market Size and Forecast (2021-2032)
    • 6.3.3 Canada Artificial Organs and Bionics Market Size and Forecast (2021-2032)
    • 6.3.4 Mexico Artificial Organs and Bionics Market Size and Forecast (2021-2032)

7 Europe

  • 7.1 Europe Artificial Organs and Bionics Consumption Value by Type (2021-2032)
  • 7.2 Europe Artificial Organs and Bionics Consumption Value by Application (2021-2032)
  • 7.3 Europe Artificial Organs and Bionics Market Size by Country
    • 7.3.1 Europe Artificial Organs and Bionics Consumption Value by Country (2021-2032)
    • 7.3.2 Germany Artificial Organs and Bionics Market Size and Forecast (2021-2032)
    • 7.3.3 France Artificial Organs and Bionics Market Size and Forecast (2021-2032)
    • 7.3.4 United Kingdom Artificial Organs and Bionics Market Size and Forecast (2021-2032)
    • 7.3.5 Russia Artificial Organs and Bionics Market Size and Forecast (2021-2032)
    • 7.3.6 Italy Artificial Organs and Bionics Market Size and Forecast (2021-2032)

8 Asia-Pacific

  • 8.1 Asia-Pacific Artificial Organs and Bionics Consumption Value by Type (2021-2032)
  • 8.2 Asia-Pacific Artificial Organs and Bionics Consumption Value by Application (2021-2032)
  • 8.3 Asia-Pacific Artificial Organs and Bionics Market Size by Region
    • 8.3.1 Asia-Pacific Artificial Organs and Bionics Consumption Value by Region (2021-2032)
    • 8.3.2 China Artificial Organs and Bionics Market Size and Forecast (2021-2032)
    • 8.3.3 Japan Artificial Organs and Bionics Market Size and Forecast (2021-2032)
    • 8.3.4 South Korea Artificial Organs and Bionics Market Size and Forecast (2021-2032)
    • 8.3.5 India Artificial Organs and Bionics Market Size and Forecast (2021-2032)
    • 8.3.6 Southeast Asia Artificial Organs and Bionics Market Size and Forecast (2021-2032)
    • 8.3.7 Australia Artificial Organs and Bionics Market Size and Forecast (2021-2032)

9 South America

  • 9.1 South America Artificial Organs and Bionics Consumption Value by Type (2021-2032)
  • 9.2 South America Artificial Organs and Bionics Consumption Value by Application (2021-2032)
  • 9.3 South America Artificial Organs and Bionics Market Size by Country
    • 9.3.1 South America Artificial Organs and Bionics Consumption Value by Country (2021-2032)
    • 9.3.2 Brazil Artificial Organs and Bionics Market Size and Forecast (2021-2032)
    • 9.3.3 Argentina Artificial Organs and Bionics Market Size and Forecast (2021-2032)

10 Middle East & Africa

  • 10.1 Middle East & Africa Artificial Organs and Bionics Consumption Value by Type (2021-2032)
  • 10.2 Middle East & Africa Artificial Organs and Bionics Consumption Value by Application (2021-2032)
  • 10.3 Middle East & Africa Artificial Organs and Bionics Market Size by Country
    • 10.3.1 Middle East & Africa Artificial Organs and Bionics Consumption Value by Country (2021-2032)
    • 10.3.2 Turkey Artificial Organs and Bionics Market Size and Forecast (2021-2032)
    • 10.3.3 Saudi Arabia Artificial Organs and Bionics Market Size and Forecast (2021-2032)
    • 10.3.4 UAE Artificial Organs and Bionics Market Size and Forecast (2021-2032)

11 Market Dynamics

  • 11.1 Artificial Organs and Bionics Market Drivers
  • 11.2 Artificial Organs and Bionics Market Restraints
  • 11.3 Artificial Organs and Bionics Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Artificial Organs and Bionics Industry Chain
  • 12.2 Artificial Organs and Bionics Upstream Analysis
  • 12.3 Artificial Organs and Bionics Midstream Analysis
  • 12.4 Artificial Organs and Bionics Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Artificial Organs and Bionics. Industry analysis & Market Report on Artificial Organs and Bionics is a syndicated market report, published as Global Artificial Organs and Bionics Market 2026 by Company, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Artificial Organs and Bionics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,690.04
    		4,035.06
    		5,380.08
    		3,239.88
    		4,859.82
    		6,479.76
    		531,361.20
    		797,041.80
    		1,062,722.40
    		293,712.00
    		440,568.00
    		587,424.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo